Smith Kevin Raymond Merrill bought INGN
March 1, 2026 · Form 4 insider transaction
Smith Kevin Raymond Merrill bought 30,012 shares of Inogen, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,012
Price
$0.00
Total value
N/A
InsiderSmith Kevin Raymond Merrill
RoleOfficer, Director
CompanyInogen, Inc. (INGN)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after147,973
OwnershipDirect
10b5-1 planNo
AmendedNo